These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8595057)
1. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers. Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057 [TBL] [Abstract][Full Text] [Related]
2. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys. Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate. Hayashi K; Kuga Y; Nomura S; Okura Y; Tanaka K; Yasunobu Y; Nomura K; Shingu T; Kuwashima J; Kajiyama G Arzneimittelforschung; 1996 Apr; 46(4):378-81. PubMed ID: 8740082 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic properties of a novel Ca2+ entry blocker, AJ-2615, in vitro. Okamura H; Fujitani B; Furukawa K; Une T; Nukuda T; Komiya M; Kurokawa M J Cardiovasc Pharmacol; 1993 Dec; 22(6):804-9. PubMed ID: 7509897 [TBL] [Abstract][Full Text] [Related]
5. Effects of monatepil maleate, a new Ca2+ channel antagonist with alpha1-adrenoceptor antagonistic activity, on cholesterol absorption and catabolism in high cholesterol diet-fed rabbits. Ikeno A; Sumiya T; Minato H; Fujitani B; Masuda Y; Hosoki K; Kurono M; Yasuba M Jpn J Pharmacol; 1998 Nov; 78(3):303-12. PubMed ID: 9869264 [TBL] [Abstract][Full Text] [Related]
6. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals. Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system. Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002 [TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [TBL] [Abstract][Full Text] [Related]
9. Long-lasting antagonistic effects of monatepil on Ca2+ current in guinea-pig ventricular cells. Nagata S; Hosoki K; Karasawa T Arzneimittelforschung; 1995 Oct; 45(10):1061-3. PubMed ID: 8595058 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine. Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512 [TBL] [Abstract][Full Text] [Related]
11. Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats. Yamamoto T; Hosoki K; Kikuta C; Karasawa T Arzneimittelforschung; 1994 Jun; 44(6):712-4. PubMed ID: 8053969 [TBL] [Abstract][Full Text] [Related]
12. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil. Sugimoto T; Hosoki K; Karasawa T J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365 [TBL] [Abstract][Full Text] [Related]
13. A new class of calcium antagonists. 2. Synthesis and biological activity of 11-[[4-[4-(4-fluorophenyl)-1-piperazinyl]butyryl]amino]-6,11- dihydrodibenzo[b,e]-thiepin maleate and related compounds. Kurokawa M; Sato F; Fujiwara I; Hatano N; Honda Y; Yoshida T; Naruto S; Mastumoto J; Uno H J Med Chem; 1991 Mar; 34(3):927-34. PubMed ID: 2002473 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive, antiatherosclerotic, and plasma lipid-lowering effects of monatepil, a novel calcium antagonist with alpha 1-adrenoceptor-blocking activity in experimental animals. Miyazaki M Am J Hypertens; 1994 Oct; 7(10 Pt 2):131S-40S. PubMed ID: 7826563 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of monatepil maleate on acyl-CoA:cholesterol acyltransferase activity in the liver of cholesterol-fed Japanese monkeys. Sumiya T; Ikeno A; Kato H; Fujitani B; Masuda Y; Hosoki K; Miyazaki M Am J Hypertens; 1997 Jul; 10(7 Pt 1):779-85. PubMed ID: 9234833 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals. Ikeno A; Nose I; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T J Cardiovasc Pharmacol; 1993 May; 21(5):815-21. PubMed ID: 7685454 [TBL] [Abstract][Full Text] [Related]
17. Idazoxan effects upon contractile activity in the rat aorta are related to alpha adrenoceptors and L-type channels. Serban DN; Serban IL; Nechifor M Fundam Clin Pharmacol; 2004 Dec; 18(6):635-41. PubMed ID: 15548234 [TBL] [Abstract][Full Text] [Related]
18. Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts. Matsunaga A; Inoue T; Koga T; Mori K; Kugi M; Sasaki J; Arakawa K Cardiovasc Drugs Ther; 1997 Dec; 11(6):747-50. PubMed ID: 9512869 [TBL] [Abstract][Full Text] [Related]